Boixeda Ramon, Bacca Sandra, Elias Lorena, Capdevila Josep Anton, Vilà Xavier, Mauri Montserrat, Almirall Jordi
Servicio de Medicina Interna, Hospital de Mataró, Consorci Sanitari del Maresme, Mataró, Barcelona, España; Departamento de Medicina, Universitat Autònoma de Barcelona, Barcelona, España.
Servicio de Medicina Interna, Hospital de Mataró, Consorci Sanitari del Maresme, Mataró, Barcelona, España; Departamento de Medicina, Universitat Autònoma de Barcelona, Barcelona, España.
Arch Bronconeumol. 2014 Dec;50(12):514-20. doi: 10.1016/j.arbres.2014.02.001. Epub 2014 Oct 25.
Pneumonia is considered an independent entity in chronic obstructive pulmonary disease (COPD), to be distinguished from an infectious exacerbation of COPD. The aim of this study was to analyze the clinical characteristics and progress of the exacerbation of COPD (ECOPD) compared to pneumonia in COPD (PCOPD) patients requiring hospitalization.
Prospective, longitudinal, observational cohort study including 124 COPD patients requiring hospital admission for lower respiratory tract infection. Patients were categorized according to presence of ECOPD (n=104) or PCOPD (n=20), depending on presence of consolidation on X-ray. Demographic, clinical, laboratory, microbiological and progress variables were collected.
Patients with ECOPD showed more severe respiratory disease according to the degree of obstruction (P<.01) and need for oxygen therapy (P<.05). PCOPD patients showed increased presence of fever (P<.05), lower blood pressure (P<.001), more laboratory abnormalities (P<.05; leukocytosis, elevated CRP, low serum albumin) and increased presence of crepitus (P<.01). Microbiological diagnosis was achieved in 30.8% of cases of ECOPD and 35% of PCOPD; sputum culture yielded the highest percentage of positive results, predominantly Pseudomonas aeruginosa. Regarding the progress of the episode, no differences were found in hospital stay, need for ICU or mechanical ventilation.
Our data confirm clinical and analytical differences between ECOPD and PCOPD in patients who require hospital admission, while there were no differences in subsequent progress.
肺炎在慢性阻塞性肺疾病(COPD)中被视为一个独立的实体,有别于COPD的感染性加重。本研究的目的是分析因需住院治疗的COPD患者中,与COPD合并肺炎(PCOPD)相比,COPD加重(ECOPD)的临床特征和病情进展。
一项前瞻性、纵向、观察性队列研究,纳入124例因下呼吸道感染需住院的COPD患者。根据X线检查有无实变,将患者分为ECOPD组(n = 104)或PCOPD组(n = 20)。收集人口统计学、临床、实验室、微生物学及病情进展变量。
根据阻塞程度(P <.01)和氧疗需求(P <.05),ECOPD患者的呼吸系统疾病更为严重。PCOPD患者发热发生率更高(P <.05)、血压更低(P <.001)、实验室异常更多(P <.05;白细胞增多、CRP升高、血清白蛋白降低)且捻发音发生率更高(P <.01)。ECOPD患者中30.8%和PCOPD患者中35%实现了微生物学诊断;痰培养阳性结果百分比最高,主要为铜绿假单胞菌。关于病情进展,住院时间、入住ICU或机械通气需求方面未发现差异。
我们的数据证实了需住院治疗的患者中ECOPD和PCOPD在临床和分析方面存在差异,而后续病情进展无差异。